We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SEAT:NASDAQVivid Seats Inc. Analysis

Data as of 2026-07-18 - not real-time

$7.09

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Vivid Seats is trading well beneath its short‑term and longer‑term moving averages, indicating a sustained price weakness. The relative strength index sits below the midpoint, suggesting neutral to slightly bearish momentum. A bullish MACD crossover provides a modest technical upside signal, yet the overall trend remains bearish. Trading volume has been contracting, reinforcing the downside pressure. Volatility is exceptionally high, making price swings unpredictable. The stock’s beta exceeds one, implying greater sensitivity to market moves. The price is close to a identified support level while still far from the next resistance barrier.
Fundamentally, revenue is contracting and margins are deep in the red, reflecting an unprofitable business model. Operating cash flow and free cash flow are negative, and the company carries a sizable debt load relative to its cash reserves. Book value per share is negative, and traditional valuation multiples such as PE and PB are nonsensical. Despite these challenges, the price‑to‑sales multiple is very low, hinting at a potential upside. Analyst price targets suggest a sizable upside, though consensus recommendations are absent. The firm does not pay a dividend, eliminating any income component for investors. In sum, the stock sits at a crossroads of technical uncertainty and fundamental distress, requiring careful risk consideration.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish price trend
  • decreasing trading volume
  • negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential upside indicated by low price‑to‑sales
  • bullish MACD signal
  • ongoing fundamental weakness

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • significant upside potential from analyst targets
  • platform growth opportunities in ticket marketplace
  • low valuation multiples relative to sales

Key Metrics & Analysis

Financial Health

Revenue Growth-23.30%
Profit Margin-82.25%
P/E Ratio-1.9
ROE-284.31%
ROA-3.32%
P/B Ratio-0.8
Op. Cash Flow$-20304000
Free Cash Flow$-10885250
Industry P/E16.1

Technical Analysis

TrendBearish
RSI46.3
Support$5.88
Resistance$8.68
MA 20$7.11
MA 50$7.94
MA 200$8.03
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Target Price$10.37
Upside/Downside46.24%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.47
Volatility88.52%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.